Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,253 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phlorizin: a review.
Ehrenkranz JR, Lewis NG, Kahn CR, Roth J. Ehrenkranz JR, et al. Among authors: roth j. Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):31-8. doi: 10.1002/dmrr.532. Diabetes Metab Res Rev. 2005. PMID: 15624123 Review.
Urgent call for the third wish.
Roth J, Holloszy JO. Roth J, et al. Diabetes Metab Res Rev. 2013 Jan;29(1):98-100. doi: 10.1002/dmrr.2374. Diabetes Metab Res Rev. 2013. PMID: 23300148
Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012.
Roth J, Pozzilli P. Roth J, et al. Diabetes Metab Res Rev. 2012 May;28(4):325. doi: 10.1002/dmrr.2267. Diabetes Metab Res Rev. 2012. PMID: 22576779 No abstract available.
Insulin's discovery: new insights on its ninetieth birthday.
Roth J, Qureshi S, Whitford I, Vranic M, Kahn CR, Fantus IG, Dirks JH. Roth J, et al. Diabetes Metab Res Rev. 2012 May;28(4):293-304. doi: 10.1002/dmrr.2300. Diabetes Metab Res Rev. 2012. PMID: 22576778 Review.
Can 'personalized diagnostics' promote earlier intervention for dysglycaemia? Hypothesis ready for testing.
Dankner R, Danoff A, Roth J. Dankner R, et al. Among authors: roth j. Diabetes Metab Res Rev. 2010 Jan;26(1):7-9. doi: 10.1002/dmrr.1039. Diabetes Metab Res Rev. 2010. PMID: 20101654
Lessons learned from the 1-hour post-load glucose level during OGTT: Current screening recommendations for dysglycaemia should be revised.
Bergman M, Jagannathan R, Buysschaert M, Pareek M, Olsen MH, Nilsson PM, Medina JL, Roth J, Chetrit A, Groop L, Dankner R. Bergman M, et al. Among authors: roth j. Diabetes Metab Res Rev. 2018 Jul;34(5):e2992. doi: 10.1002/dmrr.2992. Epub 2018 Mar 24. Diabetes Metab Res Rev. 2018. PMID: 29460410
The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention.
Dankner R, Bergman M, Danoff A, Qureshi S, Whitford I, Kaviani N, Dynkevich Y, Roth J. Dankner R, et al. Among authors: roth j. Diabetes Metab Res Rev. 2013 Jan;29(1):1-7. doi: 10.1002/dmrr.2373. Diabetes Metab Res Rev. 2013. PMID: 23175191 Review.
Biomedical meetings and biomedical journals: vive la difference et vive la compagnie.
Roth J. Roth J. Diabetes Metab Res Rev. 2010 Nov;26(8):598. doi: 10.1002/dmrr.1142. Diabetes Metab Res Rev. 2010. PMID: 21049543
Newly diagnosed type 2 diabetes may serve as a potential marker for pancreatic cancer.
Dankner R, Freedman LS, Gerstein HC, Roth J, Keinan-Boker L. Dankner R, et al. Among authors: roth j. Diabetes Metab Res Rev. 2018 Sep;34(6):e3018. doi: 10.1002/dmrr.3018. Epub 2018 Jun 17. Diabetes Metab Res Rev. 2018. PMID: 29673046
The brighter (and evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma cruzi infection in CD-1 mice.
Brima W, Eden DJ, Mehdi SF, Bravo M, Wiese MM, Stein J, Almonte V, Zhao D, Kurland I, Pessin JE, Zima T, Tanowitz HB, Weiss LM, Roth J, Nagajyothi F. Brima W, et al. Among authors: roth j. Diabetes Metab Res Rev. 2015 May;31(4):346-359. doi: 10.1002/dmrr.2636. Epub 2015 Mar 6. Diabetes Metab Res Rev. 2015. PMID: 25613819 Free PMC article.
4,253 results
Jump to page
Feedback